Living in places with more air pollution raises the risk of eczema, a chronic condition that causes dry, itchy and inflamed ...

People living in areas with higher levels of air pollution are more likely to have eczema, according to a new study.

Anzupgo is the first topical pan-Janus kinase (JAK) inhibitor to be approved in Switzerland specifically for moderate to ...

People living in areas with higher levels of air pollution are more likely to have eczema, according to a new study published ...

The odds of eczema are increased with greater exposure to fine particulate matter of diameter ≤2.5 μm (PM2.5), according to a ...

People living in areas with higher levels of air pollution are more likely to have eczema, according to a new study published ...

Research from Yale School of Medicine indicates a strong link between air pollution levels and eczema prevalence in the U.S.

Eczema affects an estimated 20 per cent of children and 11 per cent of adults in Singapore. In its moderate to severe form, ...

The indication is for the treatment of moderate to severe chronic hand eczema (CHE) in adults who have had an inadequate ...

The prevalence of eczema has increased globally with industrialization ... covering hundreds of thousands of U.S. adults. The current study included 286,862 people for whom there was available ...

Eli Lilly’s Ebglyss (lebrikizumab-lbkz) showed improvement in skin clearance and itch relief for most patients with ...

Axicabtagene ciloleucel, known by the brand name Yescarta, has been accepted for treating adults with two types of blood cancer.